Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Stanford University
Information provided by (Responsible Party):
Stanford University Identifier:
First received: May 7, 2009
Last updated: October 18, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2022
  Estimated Primary Completion Date: December 2022 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):